Qualigens Pharma Private Limited Furosemide Export Data — India (DGFT 2022–2026)

Name: Qualigens Pharma Private Limited Furosemide Export Records India — #14 Exporter, 31 Shipments, $1.2M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Furosemide

India Pharmaceutical Trade Intelligence

$70.5M333 Suppliers150 CountriesHS 30049099

ExportsIndia → UNITED STATES60.2%India → CANADA7.3%

ImportsCANADA → India$79.8K GERMANY → India$43.9K

#1 Supplier: BAXTER PHARMACEUTICALS #1 Buyer: BAXTER HEALTHCARE

Qualigens Pharma Private Limited — Furosemide Exporter #14 | $1.2M Trade Value | TransData Nexus | TransData Nexus

Qualigens Pharma Private Limited — Furosemide Exporter Profile

Indian Pharmaceutical Exporter · #14 for Furosemide · $1.2M export value · DGFT Verified

Qualigens Pharma Private Limited is the #14 Indian exporter of Furosemide with $1.2M in export value and 31 verified shipments. Qualigens Pharma Private Limited holds a 1.8% market share in Furosemide exports across 1 countries. The company exports 3 pharmaceutical products worth $8.2M across 3 therapeutic categories.

Qualigens Pharma Private Limited — Furosemide Export Profile: Buyers & Destinations

Qualigens Pharma Private Limited Furosemide export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Furosemide?

Country	Value	Shipments	Share
UNITED STATES	$42.5M	2,058	66.6%
CANADA	$5.1M	103	8.0%
FRANCE	$4.3M	156	6.8%
GERMANY	$2.1M	66	3.2%

Who Are the Top Buyers of Furosemide from India?

Buyer	Country	Value	Orders
RISING PHARMA HOLDINGS, INC.	UNITED STATES	$6.3M	969
RISING PHARMA HOLDINGS INC	UNITED STATES	$4.2M	373
RISING PHARMA HOLDINGS INC,.,	UNITED STATES	$3.6M	369
BAXTER HEALTHCARE CORPORATION	UNITED STATES	$3.1M	62
SALUTAS PHARMA GMBH	GERMANY	$2.1M	64
VIATRIS SANTE	FRANCE	$1.6M	33
AVET PHARMACEUTICALS INC.	UNITED STATES	$1.5M	35
MARCAN PHARMACEUTICALS INC.,	CANADA	$1.2M	24
ATHENEX PHARMACEUTICAL DIVISION	UNITED STATES	$1.1M	23
HOSPIRA INC	UNITED STATES	$400.0K	8

India's Furosemide is purchased by 778 buyers worldwide. The top buyer is RISING PHARMA HOLDINGS, INC. (UNITED STATES), followed by RISING PHARMA HOLDINGS INC and RISING PHARMA HOLDINGS INC,.,.

How Does Qualigens Pharma Private Limited Compare to Nearest Furosemide Exporters?

Exporters ranked immediately above and below #14 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
12	AUROBINDO PHARMA LTD	$1.3M	88	2	$14.6K
13	FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED	$1.2M	56	4	$22.2K
14	QUALIGENS PHARMA PRIVATE LIMITED ★	$1.2M	31	1	$40.2K
15	GLAND PHARMA LTD	$995.3K	28	4	$35.5K
10	LINCOLN PHARMACEUTICALS LTD	$700.0K	14	3	$50.0K

Qualigens Pharma Private Limited ranks #14 among 333 Indian Furosemide exporters. Average shipment value of $40.2K compared to the market average of $131.0K. The closest competitors by value are AUROBINDO PHARMA LTD and FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED.

Which Indian Ports Ship Furosemide Exports?

Port	Shipments	% Share
HYDERABAD ICD	828	17.8%
HYDERABAD ICD (INSNF6)	527	11.3%
SAHAR AIR	417	9.0%
SAHAR AIR CARGO ACC (INBOM4)	401	8.6%
NHAVA SHEVA SEA (INNSA1)	312	6.7%
ICD SANATHNAGAR, HYD	162	3.5%
JNPT/ NHAVA SHEVA SEA	137	2.9%
HYDERABAD AIR	129	2.8%

Geopolitical & Trade Policy Impact on Qualigens Pharma Private Limited's Furosemide Exports

The ongoing Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to alter trade routes. This has resulted in extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes. (livemint.com) For Qualigens, these disruptions translate to higher shipping costs and potential delays in fulfilling European orders, affecting customer satisfaction and profitability.

In the United States, the imposition of tariffs on pharmaceutical imports poses a challenge for Indian exporters. While generics remain exempt from the 100% tariffs, any future expansion of the tariff regime to generics and biosimilars could disproportionately impact India, which supplies almost 40% of US generics. (orfonline.org) This situation necessitates strategic planning for Qualigens to maintain its competitive edge in the U.S. market.

Conversely, the India–European Union Free Trade Agreement, concluded on January 27, 2026, offers a favorable development. The agreement eliminates tariffs on most European pharmaceutical exports to India and vice versa, potentially enhancing Qualigens' access to the European market. (en.wikipedia.org) This could offset some of the adverse effects of other geopolitical challenges.

Qualigens Pharma Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set stringent guidelines to ensure product safety and efficacy. Any lapses can lead to import bans or recalls, severely impacting a company's reputation and financial standing.

For Qualigens, maintaining compliance is critical, especially given its focused product portfolio. Investing in robust quality control systems and staying abreast of evolving regulations will be essential to sustain and grow its export business. Additionally, the company must be prepared to adapt to new regulatory frameworks that may arise from geopolitical developments, such as the EU's falsified medicines directive compliance requirements.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Furosemide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Qualigens Pharma Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 150+ countries, 778+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Furosemide

Furosemide

Qualigens Pharma Private Limited — Furosemide Exporter Profile

Qualigens Pharma Private Limited — Furosemide Export Profile: Buyers & Destinations

Where Does India Export Furosemide?

Who Are the Top Buyers of Furosemide from India?

What Is India's Total Furosemide Export Value and How Much Does Qualigens Pharma Private Limited Contribute?

What Is the Average Shipment Value for Qualigens Pharma Private Limited's Furosemide Exports?

How Does Qualigens Pharma Private Limited Compare to Other Indian Furosemide Exporters?

Regulatory Requirements: Exporting Furosemide to Key Markets

United States — FDA

Canada — HC

How Does Qualigens Pharma Private Limited Compare to Nearest Furosemide Exporters?

Which Indian Ports Ship Furosemide Exports?

Geopolitical & Trade Policy Impact on Qualigens Pharma Private Limited's Furosemide Exports

Qualigens Pharma Private Limited — Regulatory Compliance & Quality Standards

About Qualigens Pharma Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Furosemide Export Data from Qualigens Pharma Private Limited

Furosemide Stats

Company Overview

Top Products by Qualigens Pharma Private Limited

Related Analysis

Need Detailed Export Data?

Data Source